Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Androgen receptor variation affects prostate cancer progression and drug resistance.

Pharmacological research - 1 Dec 2016

McCrea Edel, Sissung Tristan M, Price Douglas K, Chau Cindy H, Figg William D

Abstract excerpt

Significant therapeutic progress has been made in treating prostate cancer in recent years. Drugs such as enzalutamide, abiraterone, and cabazitaxel have expanded the treatment armamentarium, although it is not completely clear which of these drugs are the most-effective option for individual patients. Moreover, such advances have been tempered by the development of therapeutic resistance. The purpose of this...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Disease Progression
Share to Drug Resistance, Neoplasm

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genetic Variation

Share to Genotype

Share to Prostate

Share to Prostatic Neoplasms

Share to Receptors, Androgen

Source

Open in PubMed Open full text

Identifiers

PMID: 27725309
DOI: 10.1016/j.phrs.2016.10.001
PMCID: PMC5154811

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Androgen receptor variation affects prostate cancer progression and drug resistance.PMID 27725309Read ↗

Biologic and clinical significance of androgen receptor variants in castration resistant prostate cancer.Semantic proximity Read ↗

Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical ApplicationsSemantic proximity Read ↗

Androgen receptor mutations for precision medicine in prostate cancer.Semantic proximity Read ↗

Splice variants of androgen receptor and prostate cancerSemantic proximity Read ↗

AR Splicing Variants and Resistance to AR Targeting AgentsSemantic proximity Read ↗

New Opportunities for Targeting the Androgen Receptor in Prostate Cancer.Semantic proximity Read ↗

Androgen receptor variant-driven prostate cancer: clinical implications and therapeutic targeting.Semantic proximity Read ↗

Mechanisms of resistance to androgen deprivation therapy in prostate cancer.Semantic proximity Read ↗

Androgen receptor plasticity and its implications for prostate cancer therapy.Semantic proximity Read ↗

Clinical Relevance of Androgen Receptor Splice Variants in Castration-Resistant Prostate CancerSemantic proximity Read ↗

Androgen Receptor Signaling in Prostate Cancer and Therapeutic StrategiesSemantic proximity Read ↗

The molecular biology of prostate cancer: current understanding and clinical implications.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.